2025 年全球 DNA 与基因晶片市场报告

预计未来几年 DNA 和基因晶片市场将快速成长。到 2029 年，这一数字将成长到 153.5 亿美元，年复合成长率（CAGR）为 13.4%。预测期内的成长可归因于精准医疗的进步、生物标记发现的扩大、个人化治疗药物的成长、癌症研究的应用以及研究经费的增加。预测期内的主要趋势包括技术进步、产品创新、法律规范和合规性、关注罕见疾病以及持续降低成本。

DNA 和基因晶片市场正在经历强劲成长，主要受早期癌症检测需求不断增长的推动。癌症是一个普遍的健康问题，迫切需要能够及时识别癌症的技术。 DNA 和基因晶片在测量基因表现、了解遗传状况和评估癌细胞中的基因组调控元件方面发挥关键作用。尤其是美国癌症协会估计，2022年美国将有190万新发癌症病例，609,360人死于癌症，强调了DNA和基因晶片在推进早期癌症检测方面将发挥的重要作用。

对个人化医疗的日益重视预计将推动 DNA 和基因晶片市场的成长。个人化医疗是医疗保健领域的新兴方法，它利用个人的基因特征来指导疾病预防、诊断和治疗的决策。 DNA 或基因晶片透过分析个人的基因特征来识别潜在的疾病风险和治疗方案，在个人化医疗中发挥关键作用。例如，2022 年 10 月，美国健康报导机构STAT 报道称，目前有超过 75,000 种基因检测产品和超过 300 种个人化药物可供选择。因此，人们对个人化医疗日益增长的兴趣推动了 DNA 和基因晶片市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第 4 章 市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情以及復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球DNA与基因晶片PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素、限制因素）
• 最终用途产业分析
• 全球 DNA 与基因晶片市场：成长率分析
• 全球 DNA 和基因晶片市场表现：规模和成长，2019 年至 2024 年
• 全球 DNA 和基因晶片市场预测：规模和成长，2024-2029 年，2034 年
• 全球 DNA 和基因晶片总目标市场 (TAM)

第六章 市场细分

• 全球 DNA 与基因晶片市场类型、效能及预测，2019-2024 年、2024-2029 年、2034 年
• 寡核苷酸 DNA（o-DNA）
• 互补DNA（cDNA）
• 其他类型
• 全球 DNA 和基因晶片市场（按应用、性能和预测），2019-2024 年、2024-2029 年、2034 年
• 癌症诊断
• 基因表现
• 蛋白质体学
• 基因组学
• 药物研发
• 农业基因组学
• 其他用途
• 全球 DNA 和基因晶片市场（按最终用户、业绩和预测），2019-2024 年、2024-2029 年、2034 年
• 学术和政府研究组织
• 生技及製药公司
• 医院和诊断中心
• 其他最终用户
• 全球 DNA 和基因晶片市场：寡核苷酸 DNA (o-DNA) 细分市场、类型、性能和预测，2019-2024 年、2024-2029F、2034F
• 自订寡核苷酸晶片
• 市售寡核苷酸阵列
• 全球 DNA 和基因晶片市场：互补 DNA (c-DNA) 细分市场、类型、性能和预测，2019-2024 年、2024-2029F、2034F
• cDNA微阵列
• cDNA表现阵列
• 全球 DNA 和基因晶片市场：按类型、实际和预测细分，2019-2024 年、2024-2029 年、2034 年
• 单细胞RNA定序晶片
• SNP（单核苷酸多态性）晶片
• 全基因组扩增晶片

第七章 区域和国家分析

• 全球 DNA 和基因晶片市场：按地区、表现和预测，2019-2024 年、2024-2029 年、2034 年
• 全球 DNA 和基因晶片市场：按国家/地区、绩效和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第 17 章 德国市场

第 18 章 法国市场

第 19 章：义大利市场

第 20 章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第 25 章：加拿大市场

第26章 南美洲市场

第 27 章：巴西市场

第28章 中东市场

第 29 章：非洲市场

第 30 章竞争格局与公司概况

• DNA 与基因晶片市场：竞争格局
• DNA 与基因晶片市场：公司简介
  • PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Macrogen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

• Greiner Bio-One International GmbH
• CapitalBio Corporation
• Microarrays Inc.
• bioMerieux SA
• Applied Microarrays Inc.
• Biometrix Technology Inc.
• Oxford Gene Technology IP Limited
• Bioneer Corporation
• Eurofins MWG Operon LLC
• F. Hoffmann-La Roche Ltd
• QIAGEN NV
• Bio-Rad Laboratories Inc.
• BioChain Institute Inc.
• Cepheid
• Eppendorf AG

第 32 章 全球市场竞争基准化分析与仪表板

第33章 重大併购

第 34 章 近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

• 2029 年 DNA 与基因晶片市场：提供新机会的国家
• 2029 年 DNA 与基因晶片市场：提供新机会的细分市场
• DNA 与基因晶片市场 2029：成长策略
  • 基于市场趋势的策略
  • 竞争对手的策略

第 36 章 附录

A DNA and gene chip is a microchip featuring microscopic DNA probes attached to a solid surface, capable of identifying DNA from test samples and constituting one half of the DNA double helix. When the test sample of DNA carries a mutation, the DNA fails to bind properly to the sequence on the chip. This technology is employed to measure the expression levels of genes or determine whether a person's DNA exhibits mutations, variations in DNA that can lead to diseases.

The main types of DNA and gene chips include oligonucleotide DNA (O-DNA), complementary DNA (C-DNA), and other variations. Oligonucleotide DNA comprises short single- or double-stranded DNA or RNA fragments with three to twenty nucleotides. Products associated with this technology include consumables and instruments, with applications ranging from cancer diagnostics, gene expression, proteomics, genomics, drug discovery, to agrigenomics. End-user industries involved encompass academic and government research institutes, biotechnology and pharmaceutical companies, hospitals and diagnostics centers, among others.

The DNA and gene chips market research report is one of a series of new reports from The Business Research Company that provides DNA and gene chips market statistics, including DNA and gene chips industry global market size, regional shares, competitors with a DNA and gene chips market share, detailed DNA and gene chips market segments, market trends and opportunities, and any further data you may need to thrive in the DNA and gene chips industry. This DNA and gene chips market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The DNA and gene chip market size has grown rapidly in recent years. It will grow from $8.19 billion in 2024 to $9.27 billion in 2025 at a compound annual growth rate (CAGR) of 13.1%. The growth in the historic period can be attributed to genomic research advancements, rise of personalized medicine, human genome project milestones, drug discovery and development, disease biomarker identification.

The DNA and gene chip market size is expected to see rapid growth in the next few years. It will grow to $15.35 billion in 2029 at a compound annual growth rate (CAGR) of 13.4%. The growth in the forecast period can be attributed to advancements in precision medicine, expansion of biomarker discovery, growth of personalized therapeutics, application in cancer research, increasing research funding. Major trends in the forecast period include technological advancements, product innovations, regulatory framework and compliance, focus on rare diseases, continuous reduction in costs.

The DNA and gene chip market is experiencing substantial growth, primarily fueled by the escalating demand for early cancer detection. Cancer, a pervasive health concern, prompts an urgent need for technologies facilitating timely identification. DNA and gene chips play a pivotal role in measuring gene expression, understanding genetic landscapes, and assessing genomic regulatory elements in cancer cells. Notably, the American Cancer Society estimates approximately 1.9 million new cancer cases and 609,360 deaths in the United States for 2022, emphasizing the critical role of DNA and gene chips in advancing early cancer detection.

The growing emphasis on personalized medicine is anticipated to drive the expansion of the DNA and gene chip market in the future. Personalized medicine is an emerging approach in healthcare that utilizes an individual's genetic profile to inform decisions regarding disease prevention, diagnosis, and treatment. DNA and gene chips play a crucial role in personalized medicine by analyzing a person's genetic profile to identify potential disease risks and treatment options. For example, in October 2022, reports from STAT, a US-based health-focused news organization, indicated that there were over 75,000 genetic testing products and 300 personalized medicines available. Consequently, the heightened focus on personalized medicine is fueling the growth of the DNA and gene chip market.

Strategic partnerships and collaborations are emerging as significant trends in the DNA and gene chip market. Many companies in this field are seeking alliances to enhance their positions within the DNA and gene chip market. For example, in June 2022, Avesthagen Limited, an India-based integrated systems biology platform company, established a four-year strategic partnership with Wipro Limited, an India-based information technology firm. This collaboration involves executing the project titled "Cancer Risk Assessed by NGS profiling of circulating free DNA and RNA for lung cancer," which focuses on genomics sequencing services. Additionally, in May 2022, Thermo Fisher Scientific, a US-based supplier of analytical instruments, partnered with the Qatar Genome Program (QGP), part of the Qatar Foundation (QF), to develop a custom Axiom genotyping array for pan-Arab populations using whole genome sequencing data from 19 Arab countries. This array, featuring 800,000 variants, aims to enhance genomic research on conditions such as diabetes, cardiovascular diseases, autism, and cancer. The collaboration supports Qatar's national vision for improved population health and the advancement of precision medicine for Arab individuals globally, facilitated by Thermo Fisher's Axiom microarray technology, which accelerates precision medicine initiatives.

Key players in the DNA and gene chip market are developing innovative genotyping chips, such as the Axiom YNS_Mol1, to advance the food industry and promote insect consumption. The Axiom YNS_Mol1 is a genotyping chip specifically designed for insect breeding, particularly for the Tenebrio Molitor mealworm. For instance, in June 2023, Ynsect, a France-based company specializing in insect production, introduced the world's first genotyping chip for insect breeding, the Axiom YNS_Mol1. Developed in collaboration with Thermo Fisher Scientific, this pioneering chip aims to transform insect breeding for sustainable food and pet food production. It analyzes genetic traits to enhance genomic diversity and improve characteristics such as growth, reproduction, and disease resistance in Tenebrio Molitor mealworms. This innovative initiative is part of Ynsect's YnFABRE project, contributing to the advancement of entomoculture and sustainable solutions in addressing environmental challenges.

In December 2022, The Merck Group, a German-based science and technology company that offers DNA and gene chips, signed a Memorandum of Understanding (MoU) with Synplogen. This partnership aims to advance the development, manufacturing, and testing of viral vector-based gene therapies in Japan. Additionally, Merck will provide practical training for Synplogen's scientists at its M Lab Collaboration Center in Tokyo, facilitating knowledge transfer and technical assistance. Synplogen Co. Ltd. is a Japan-based company specializing in DNA synthesis.

Major companies operating in the DNA and gene chip market are PerkinElmer Inc., Illumina Inc., Thermo Fisher Scientific Inc., Macrogen Inc., Agilent Technologies Inc., Greiner Bio-One International GmbH, CapitalBio Corporation, Microarrays Inc., bioMerieux SA, Applied Microarrays Inc., Biometrix Technology Inc., Oxford Gene Technology IP Limited, Bioneer Corporation, Eurofins MWG Operon LLC, F. Hoffmann-La Roche Ltd, QIAGEN N.V., Bio-Rad Laboratories Inc., BioChain Institute Inc., Cepheid, Eppendorf AG, Fluidigm Corporation, GE Healthcare, Genisphere LLC, Gyros Protein Technologies AB, Hitachi High-Technologies Corporation, LC Sciences

North America was the largest region in the DNA and gene chip market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dna and gene chip market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the dna and gene chip market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The DNA and gene chip market consists of sales of instrumentation and consumables. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

DNA And Gene Chip Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dna and gene chip market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dna and gene chip ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dna and gene chip market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Oligonucleotide DNA (o-DNA); Complementary DNA (c-DNA); Other Types
• 2) By Application: Cancer Diagnostics; Gene Expression; Proteomics; Genomics; Drug Discovery; Agrigenomics; Other Applications
• 3) By End User: Academic And Government Research Institutes; Biotechnology And Pharmaceutical Companies; Hospitals And Diagnostics Centers; Other End Users
• Subsegments:
• 1) By Oligonucleotide DNA (o-DNA): Custom Oligonucleotide Chips; Commercial Oligonucleotide Arrays
• 2) By Complementary DNA (c-DNA): cDNA Microarrays; cDNA Expression Arrays
• 3) By Other Types: Single-Cell RNA Sequencing Chips; SNP (Single Nucleotide Polymorphism) Chips; Whole Genome Amplification Chips
• Companies Mentioned: PerkinElmer Inc.; Illumina Inc.; Thermo Fisher Scientific Inc.; Macrogen Inc.; Agilent Technologies Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. DNA And Gene Chip Market Characteristics

3. DNA And Gene Chip Market Trends And Strategies

4. DNA And Gene Chip Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global DNA And Gene Chip Growth Analysis And Strategic Analysis Framework

• 5.1. Global DNA And Gene Chip PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global DNA And Gene Chip Market Growth Rate Analysis
• 5.4. Global DNA And Gene Chip Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global DNA And Gene Chip Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global DNA And Gene Chip Total Addressable Market (TAM)

6. DNA And Gene Chip Market Segmentation

• 6.1. Global DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oligonucleotide DNA (o-DNA)
• Complementary DNA (c-DNA)
• Other Types
• 6.2. Global DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cancer Diagnostics
• Gene Expression
• Proteomics
• Genomics
• Drug Discovery
• Agrigenomics
• Other Applications
• 6.3. Global DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Academic And Government Research Institutes
• Biotechnology And Pharmaceutical Companies
• Hospitals And Diagnostics Centers
• Other End Users
• 6.4. Global DNA And Gene Chip Market, Sub-Segmentation Of Oligonucleotide DNA (o-DNA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Custom Oligonucleotide Chips
• Commercial Oligonucleotide Arrays
• 6.5. Global DNA And Gene Chip Market, Sub-Segmentation Of Complementary DNA (c-DNA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• cDNA Microarrays
• cDNA Expression Arrays
• 6.6. Global DNA And Gene Chip Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Cell RNA Sequencing Chips
• SNP (Single Nucleotide Polymorphism) Chips
• Whole Genome Amplification Chips

7. DNA And Gene Chip Market Regional And Country Analysis

• 7.1. Global DNA And Gene Chip Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global DNA And Gene Chip Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific DNA And Gene Chip Market

• 8.1. Asia-Pacific DNA And Gene Chip Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China DNA And Gene Chip Market

• 9.1. China DNA And Gene Chip Market Overview
• 9.2. China DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India DNA And Gene Chip Market

• 10.1. India DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan DNA And Gene Chip Market

• 11.1. Japan DNA And Gene Chip Market Overview
• 11.2. Japan DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia DNA And Gene Chip Market

• 12.1. Australia DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia DNA And Gene Chip Market

• 13.1. Indonesia DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea DNA And Gene Chip Market

• 14.1. South Korea DNA And Gene Chip Market Overview
• 14.2. South Korea DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe DNA And Gene Chip Market

• 15.1. Western Europe DNA And Gene Chip Market Overview
• 15.2. Western Europe DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK DNA And Gene Chip Market

• 16.1. UK DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany DNA And Gene Chip Market

• 17.1. Germany DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France DNA And Gene Chip Market

• 18.1. France DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy DNA And Gene Chip Market

• 19.1. Italy DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain DNA And Gene Chip Market

• 20.1. Spain DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe DNA And Gene Chip Market

• 21.1. Eastern Europe DNA And Gene Chip Market Overview
• 21.2. Eastern Europe DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia DNA And Gene Chip Market

• 22.1. Russia DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America DNA And Gene Chip Market

• 23.1. North America DNA And Gene Chip Market Overview
• 23.2. North America DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA DNA And Gene Chip Market

• 24.1. USA DNA And Gene Chip Market Overview
• 24.2. USA DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada DNA And Gene Chip Market

• 25.1. Canada DNA And Gene Chip Market Overview
• 25.2. Canada DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America DNA And Gene Chip Market

• 26.1. South America DNA And Gene Chip Market Overview
• 26.2. South America DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil DNA And Gene Chip Market

• 27.1. Brazil DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East DNA And Gene Chip Market

• 28.1. Middle East DNA And Gene Chip Market Overview
• 28.2. Middle East DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa DNA And Gene Chip Market

• 29.1. Africa DNA And Gene Chip Market Overview
• 29.2. Africa DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. DNA And Gene Chip Market Competitive Landscape And Company Profiles

• 30.1. DNA And Gene Chip Market Competitive Landscape
• 30.2. DNA And Gene Chip Market Company Profiles
  • 30.2.1. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Macrogen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. DNA And Gene Chip Market Other Major And Innovative Companies

• 31.1. Greiner Bio-One International GmbH
• 31.2. CapitalBio Corporation
• 31.3. Microarrays Inc.
• 31.4. bioMerieux SA
• 31.5. Applied Microarrays Inc.
• 31.6. Biometrix Technology Inc.
• 31.7. Oxford Gene Technology IP Limited
• 31.8. Bioneer Corporation
• 31.9. Eurofins MWG Operon LLC
• 31.10. F. Hoffmann-La Roche Ltd
• 31.11. QIAGEN N.V.
• 31.12. Bio-Rad Laboratories Inc.
• 31.13. BioChain Institute Inc.
• 31.14. Cepheid
• 31.15. Eppendorf AG

32. Global DNA And Gene Chip Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The DNA And Gene Chip Market

34. Recent Developments In The DNA And Gene Chip Market

35. DNA And Gene Chip Market High Potential Countries, Segments and Strategies

• 35.1 DNA And Gene Chip Market In 2029 - Countries Offering Most New Opportunities
• 35.2 DNA And Gene Chip Market In 2029 - Segments Offering Most New Opportunities
• 35.3 DNA And Gene Chip Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer